Skip to main content
SpringerLink
Log in

Tumors of the Female Reproductive Organs

Family Medicine

  • 56 Accesses

Abstract

Leiomyoma or fibroids arise from monoclonal proliferation or numerous copies of the same or very few cells [1] and are stimulated by estrogen and progesterone. They increase their growth rate during pregnancy and regress after menopause. They vary widely in size from a few millimeters to large masses filling the entire abdomen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Viswanathan M, Hartmann K, McKoy N, Stuart G, Rankins N, Thieda P, et al. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess. 2007;154:1–122.

    Google Scholar 

  2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.

    Article  PubMed  Google Scholar 

  3. Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology. 2005;16(3):346–54.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG Int J Obstet Gy. 2017;124(10):1501–12.

    Article  CAS  Google Scholar 

  5. Food US, Administration D. FDA updated assessment of the use of laparoscopic power morcellators to treat uterine fibroids. FDA safety communication. USFDA: Silver Spring; 2017.

    Google Scholar 

  6. Donnez J, Donnez O, Matule D, Ahrendt H, Hudecek R, Zatik J, et al. Long-term medical management of uterine fibroids with ulipristal acetate. Fertil Steril. 2016;105(1):165–173.e4.

    Article  CAS  PubMed  Google Scholar 

  7. Brölmann H, Bongers M, Garza-Leal J, Gupta J, Veersema S, Quartero R, et al. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg. 2016;13:27–35.

    Article  PubMed  Google Scholar 

  8. Ghezzi F, Cromi A, Bergamini V, Scarperi S, Bolis P, Franchi M. Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas. Surg Endosc. 2007;21(11):2081–5.

    Article  PubMed  Google Scholar 

  9. Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014;12

    Google Scholar 

  10. Taheri M, Galo L, Potts C, Sakhel K, Quinn SD. Nonresective treatments for uterine fibroids: a systematic review of uterine and fibroid volume reductions. Int J Hyperth. 2019;36(1):295–301.

    Article  Google Scholar 

  11. Urman B, Yakin K, Balaban B. Recurrent implantation failure in assisted reproduction: how to counsel and manage. A. General considerations and treatment options that may benefit the couple. Reprod Biomed Online. 2005;11(3):371–81.

    Article  PubMed  Google Scholar 

  12. Morales AJ, Kettel LM, Murphy AA. Mifepristone: clinical application in general gynecology. Clin Obstet Gynecol. 1996;39(2):451–60.

    Article  CAS  PubMed  Google Scholar 

  13. Ono M, Yin P, Navarro A, Moravek MB, Coon VJS, Druschitz SA, et al. Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth. Fertil Steril. 2014;101(5):1441–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ozercan IH, Sahin N, Akdemir F, Onderci M, Seren S, Sahin K, et al. Chemoprevention of fibroid tumors by [−]-epigallocatechin-3-gallate in quail. Nutr Res. 2008;28(2):92–7.

    Article  CAS  PubMed  Google Scholar 

  15. Sahin K, Akdemir F, Tuzcu M, Sahin N, Onderci M, Ozercan R, et al. Genistein suppresses spontaneous oviduct tumorigenesis in quail. Nutr Cancer. 2009;61(6):799–806.

    Article  CAS  PubMed  Google Scholar 

  16. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.

    Article  PubMed  Google Scholar 

  17. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.

    Article  Google Scholar 

  18. Sorosky JI. Endometrial cancer. Obstet Gynecol. 2008;111(2 Pt 1):436–47.

    Article  PubMed  Google Scholar 

  19. Schnatz PF, Guile M, O'Sullivan DM, Sorosky JI. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol. 2006;107(3):701–8.

    Article  PubMed  Google Scholar 

  20. von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a gynecologic oncology group study. Cancer. 2006 15;107(12):2786–91.

    Article  Google Scholar 

  21. Sorosky JI. Endometrial cancer. Obstet Gynecol. 2012;120(2 Pt 1):383–97.

    Article  PubMed  Google Scholar 

  22. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90(18):1371–88.

    Article  CAS  PubMed  Google Scholar 

  23. Brinton LA, Hoover RN. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The endometrial Cancer collaborative group. Obstet Gynecol. 1993;81(2):265–71.

    CAS  PubMed  Google Scholar 

  24. Gordon P. Videos in clinical medicine. Endometrial biopsy. N Engl J Med. 2009;361(26):e61.

    Article  PubMed  Google Scholar 

  25. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000;89(8):1765–72.

    Article  CAS  PubMed  Google Scholar 

  26. Leitao MM Jr, Han G, Lee LX, Abu-Rustum NR, Brown CL, Chi DS, et al. Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk. Am J Obstet Gynecol. 2010;203(4):349.e1–6.

    Article  Google Scholar 

  27. Goldstein SR. The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium. Obstet Gynecol. 2009;201(1):5–11.

    Google Scholar 

  28. Goldstein SR. Modern evaluation of the endometrium. Obstet Gynecol. 2010;116(1):168–76.

    Article  PubMed  Google Scholar 

  29. Sweet MG, Schmidt-Dalton TA, Weiss PM, Madsen KP. Evaluation and management of abnormal uterine bleeding in premenopausal women. Am Fam Physician. 2012;85(1):35–43.

    PubMed  Google Scholar 

  30. Werbrouck E, Veldman J, Luts J, Van Huffel S, Van Schoubroeck D, Timmerman D, et al. Detection of endometrial pathology using saline infusion sonography versus gel instillation sonography: a prospective cohort study. Fertil Steril. 2011;95(1):285–8.

    Article  PubMed  Google Scholar 

  31. Van Den Bosch T, Van Schoubroeck D, Luts J, Bignardi T, Condous G, Epstein E, et al. Effect of gel-instillation sonography on Doppler ultrasound findings in endometrial polyps. Ultrasound Obstet Gynecol. 2011;38(3):355–9.

    Article  Google Scholar 

  32. ACOG Committee on Practice, Bulletins – Gynecology, American College of Obstetricians and, Gynecologists. ACOG practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet. 2001;72(3):263–71.

    Article  Google Scholar 

  33. Zaino RJ, Kauderer J, Trimble CL, Silverberg SG, Curtin JP, Lim PC, et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study. Cancer. 2006;106(4):804–11.

    Article  PubMed  Google Scholar 

  34. Baak JP, Mutter GL, Robboy S, van Diest PJ, Uyterlinde AM, Orbo A, et al. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005;103(11):2304–12.

    Article  CAS  PubMed  Google Scholar 

  35. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.

    Article  PubMed  Google Scholar 

  36. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.

    Article  CAS  PubMed  Google Scholar 

  37. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, et al. World: Human papillomavirus and related diseases, summary report 2019. ICO/IARC Information Centre on HPV and Cancer 6/17/19 6/17/19.

    Google Scholar 

  38. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. Cancer of the Cervix Uteri – Cancer Stat Facts Available at: https://seer.cancer.gov/statfacts/html/cervix.html. Accessed 13 Nov 2019.

  39. Ries L, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al. SEER Cancer Statistics Review, 1975–2005. Bethesda: National Cancer Institute; 2008. Available at: http://seer.cancer.gov/csr/1975_2005/. Accessed 21 Oct 2014

    Google Scholar 

  40. Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med. 1996;334(16):1030–7.

    Article  CAS  PubMed  Google Scholar 

  41. Su B, Qin W, Xue F, Wei X, Guan Q, Jiang W, et al. The relation of passive smoking with cervical cancer: a systematic review and meta-analysis. Medicine. 2018;97(46):e13061.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Moyer VA. U.S, preventive services task F. screening for cervical cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;156(12):880–91.

    Article  PubMed  Google Scholar 

  43. ACOG Committee on Practice, Bulletins – Gynecology. ACOG Practice Bulletin no. 109: cervical cytology screening. Obstet Gynecol. 2009;114(6):1409–20.

    Article  Google Scholar 

  44. Miller BA, Kolonel LN, Bernstein L. Racial/ethnic patterns of cancer in the United States 1988–1992. Bethesda: NIH Publication; 1996. 96(4101)

    Google Scholar 

  45. Moore DH. Cervical cancer. Obstet Gynecol. 2006;107(5):1152–61.

    Article  PubMed  Google Scholar 

  46. Partridge EE, Abu-Rustum NR, Campos SM, Fahey PJ, Farmer M, Garcia RL, et al. Cervical cancer screening. J Natl Compr Cancer Netw. 2010;8(12):1358–86.

    Article  Google Scholar 

  47. Jordan SE, Maliakal C, Schlumbrecht MP, Quintero L, Pearson JM, Wolfson AH, et al. Examining the utility of magnetic resonance imaging compared with physical exam in cervical cancer staging. Gynecol Oncol. 2019;154:119.

    Article  Google Scholar 

  48. Bhatla N, Berek JS, Fredes MC, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet. 2019;145(1):129–35.

    Article  Google Scholar 

  49. Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri”. Int J Gynecol Obstet. 2019;147(2):279–80. [Int J Gynecol Obstet 145(2019) 129–135]

    Article  Google Scholar 

  50. Stumbar SE, Stevens M, Feld Z. Cervical Cancer and its precursors. Prim Care. 2019;46(1):117–34.

    Article  PubMed  Google Scholar 

  51. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(7):674–86.

    Article  PubMed  Google Scholar 

  52. Final Recommendation Statement: Cervical Cancer: Screening. U.S. Preventive Services Task Force. 2019. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/cervical-cancer-screening. Accessed 15 Nov 2019.

  53. Practice Bulletin No. 117. Gynecologic care for women with human immunodeficiency virus. Obstet Gynecol. 2010;116(6):1492–509.

    Article  Google Scholar 

  54. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ. 2009;339:b2968.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62(3):147–172.

    Google Scholar 

  56. Nayar R. The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes. 3rd ed: Cham, Springer International Publishing; 2015, 2015.

    Google Scholar 

  57. Massad L, Stewart Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW, et al. 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Lower Genital Tract Disease. 2013;17(Supplement 1):S1–S27.

    Article  Google Scholar 

  58. Munoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst. 2010;102(5):325–39.

    Article  CAS  PubMed  Google Scholar 

  59. Committee on Infectious D. HPV vaccine recommendations. Pediatrics. 2012;129(3):602–5.

    Article  Google Scholar 

  60. Velentzis LS, Caruana M, Simms KT, Lew J, Shi J, Saville M, et al. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. Int J Cancer. 2017;141(12):2410–22.

    Article  CAS  PubMed  Google Scholar 

  61. Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3–14.

    Article  PubMed  Google Scholar 

  62. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

    Article  PubMed  Google Scholar 

  63. SEER. Cancer statistics. 2014. Available at: http://seer.cancer.gov/statfacts/html/ovary.html. Accessed 22 Nov 2014

  64. Cancer Stat Facts: Ovarian Cancer. 2016.; Available at: https://seer.cancer.gov/statfacts/html/ovary.html. Accessed 15 Sept 2019.

  65. Risch HA. Hormonal etiology of epithelial ovarian, cancer with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90(23):1774–86.

    Article  CAS  PubMed  Google Scholar 

  66. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst. 1999;91(17):1459–67.

    Article  CAS  PubMed  Google Scholar 

  67. Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women’s Health Initiative randomized trial. JAMA. 2003;290(13):1739–48.

    Article  CAS  PubMed  Google Scholar 

  68. Luan N, Wu Q, Gong T, Vogtmann E, Wang Y, Lin B. Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies. Am J Clin Nutr. 2013;98(4):1020–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Jordan SJ, Whiteman DC, Purdie DM, Green AC, Webb PM. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol. 2006;103(3):1122–9.

    Article  CAS  PubMed  Google Scholar 

  70. Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer. 2007;43(4):690–709.

    Article  PubMed  Google Scholar 

  71. Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br J Cancer. 2018;118(8):1123–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Goff BA, Mandel L, Muntz HG, Melancon CH. Ovarian carcinoma diagnosis. Cancer. 2000;89(10):2068–75.

    Article  CAS  PubMed  Google Scholar 

  73. Yawn BP, Barrette BA, Wollan PC. Ovarian cancer: the neglected diagnosis. Mayo Clin Proc. 2004;79(10):1277–82.

    Article  PubMed  Google Scholar 

  74. American College of Obstetricians and Gynecologists Committee on Gynecologic, Practice. Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer. Obstet Gynecol. 2011;117(3):742–6.

    Article  Google Scholar 

  75. Moyer VA. U.S, preventive services task F. screening for ovarian cancer: U.S. preventive services task force reaffirmation recommendation statement. Ann Intern Med. 2012;157(12):900–4.

    Article  PubMed  Google Scholar 

  76. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) Cancer screening randomized controlled trial. JAMA. 2011;305(22):2295–303.

    Article  CAS  PubMed  Google Scholar 

  77. Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJ, et al. Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int J Gynecol Cancer. 2006;16(Suppl 1):54–9.

    Article  PubMed  Google Scholar 

  78. Olivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol. 2006;100(1):20–6.

    Article  CAS  PubMed  Google Scholar 

  79. American College of Obstetricians and, Gynecologists, ACOG Committee on Practice, Bulletins – Gynecology, ACOG Committee on G, Society of Gynecologic O. ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009;113(4):957–66.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Family & Community Medicine, University of Arizona, College of Medicine, Tucson, AZ, USA

    Paul Gordon & Genevieve Riebe

  2. College of Medicine, University of Arizona, Tucson, AZ, USA

    Hannah M. Emerson, Faith Dickerson & Surbhi B. Patel

Authors
  1. Paul Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hannah M. Emerson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Faith Dickerson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Surbhi B. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Genevieve Riebe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Gordon .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of Nebraska, Omaha, NE, USA

    Paul Paulman

  2. Department of Family and Community Medicine, Eastern Virginia Medical School, Norfolk, VA, USA

    Robert B. Taylor

  3. Department of Family Medicine, University of Nebraska Medical Center, Omaha, NE, USA

    Audrey A. Paulman

  4. Department of Family Medicine, Creighton University, Omaha, NE, USA

    Laeth S. Nasir

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer International Publisher Switzerland

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Gordon, P., Emerson, H.M., Dickerson, F., Patel, S.B., Riebe, G. (2020). Tumors of the Female Reproductive Organs. In: Paulman, P., Taylor, R., Paulman, A., Nasir, L. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0779-3_112-2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0779-3_112-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0779-3

  • Online ISBN: 978-1-4939-0779-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Tumors of the Female Reproductive Organs
    Published:
    27 May 2020

    DOI: https://doi.org/10.1007/978-1-4939-0779-3_112-2

  2. Original

    Tumors of the Female Reproductive Organs
    Published:
    13 April 2015

    DOI: https://doi.org/10.1007/978-1-4939-0779-3_112-1

Search

Navigation